
Reporter @WSJ covering biotech. From the "Apple Capital of the World"
Joined June 2020
- Tweets330
- Following1.4K
- Followers559
- Likes896
Xavier Martinez retweeted
EXCLUSIVE: The U.S. has lost its measles-elimination status, a stunning reversal for a nation that has kept the vaccine-preventable disease at bay for decades. wsj.com/health/u-s-loses-mea… from @l_e_whyte + me
Xavier Martinez retweeted
EXCLUSIVE: The U.S. has lost its measles elimination status.
with @JenCalfas - free link: wsj.com/health/u-s-loses-mea…
Xavier Martinez retweeted
Nvidia’s Disappearing Singapore Sales Deepen Mystery Around Megaspeed | My latest @WSJheard @WSJ $NVDA wsj.com/business/earnings/nv…
Xavier Martinez retweeted
EXCLUSIVE: Nvidia's board is moving to oust CEO Jensen Huang: wsj.com/business/nvidia-is-p…
We wrote about this disconnect between silicon valley and biopharma executives last week
Drugmakers say ai can do great things in bio, even generate brand new drugs that have great potential
But "cure" is a big word (see $VRTX's Jeff Leiden below)
Xavier Martinez retweeted
A new type of blood thinner from @Bayer was just approved by @FDA. It is the first shown in testing to prevent repeat strokes without significantly increasing a person’s bleeding risk. Our story below:
wsj.com/health/pharma/new-ty…
Xavier Martinez retweeted
AstraZeneca recently made a roughly $10 billion offer to buy Rhythm Pharmaceuticals, a deal that would expand its portfolio of rare disease treatments on.wsj.com/4A7zDfV
Exclusive w/ @laurenthomas: AstraZeneca recently made a $10 billion offer to buy Rhythm Pharmaceuticals, a Boston-based company that makes drugs for rare metabolic conditions.
AstraZeneca had previously expressed interest in Rhythm.
Link in thread...
Xavier Martinez retweeted
Dr. Annie Andrews, a pediatrician and gun-safety advocate, has defeated Republican Sen. Darline Graham for a South Carolina Senate seat, according to the Associated Press. She’s the first Democratic senator to be elected in the state since 1998. on.wsj.com/4AgLUPr
Xavier Martinez retweeted
Replying to @MHackman
@MHackman is one of the coolest people I know, and in this amazing video she takes you to her Persian Jewish community to explore the complicated politics of the ongoing war in Iran. Definitely worth watching: wsj.com/video/series/rooted-…
Xavier Martinez retweeted
NEW:
"A 37-year-old Genentech scientist died in his San Francisco home last month of an overdose from a dangerous new opioid found in products sold openly in smoke shops and gas stations."
By @abineely and @alyce_mcf sfchronicle.com/sf/article/k…
Xavier Martinez retweeted
Exclusive: A new Labor Department regulation aims to pry open the business model of PBMs, powerful companies that oversee hundreds of billions of dollars’ worth of drug spending on.wsj.com/3W8xodS
Xavier Martinez retweeted
To the scientific world, Moderna’s cancer vaccine’s results proved that a highly personalized, immune-targeting medication can work. To investors, it didn’t work well enough. W/ @xavierjohnm:
wsj.com/health/pharma/modern…
Xavier Martinez retweeted
EXCLUSIVE - Top RFK Jr. ally and adviser Calley Means has quit the Trump administration.
Means was frustrated by White House delays of some of Kennedy’s popular food policies and blamed others in the administration for allowing food companies and special interests to have too much sway, people familiar with the matter said.
One of them described him as “disillusioned.” wsj.com/politics/policy/call…
Xavier Martinez retweeted
#ESMO26: The embargo on LBA1, “INTerpath-001: Phase 3 study of the mRNA-based individualised neoantigen therapy intismeran autogene plus pembrolizumab versus pembrolizumab alone for adjuvant treatment of resected stage IIB-IV melanoma”, has been breached. As the data are now publicly available, ESMO has released the information contained in the abstract and has lifted the embargo on the full dataset.













